Supplementary Figure S1 from Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I–inhibiting Antibody–Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab GovitecanJhanelle E. Gray,Rebecca S. Heist,Alexander N. Starodub,D. Ross Camidge,Ebenezer A. Kio,Gregory A. Masters,W. Thomas Purcell,Michael J. Guarino,Jamal Misleh,Charles J. Schneider,Bryan J. Schneider,Allyson Ocean, Tirrell Johnson,Leena Gandhi,Kevin Kalinsky,Ronald Scheff,Wells A. Messersmith,Serengulam V. Govindan,Pius P. Maliakal,Boyd Mudenda,William A. Wegener,Robert M. Sharkey,David M. Goldenbergcrossref（2023）引用 0|浏览1暂无评分摘要Case Study 2: Response assessment by CT with Trop-2 expresssion by immunohistology更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
